Critical Point ranks 7 on the Humanoids 100 with a score of 87; Proception ranks 97 with 51. Critical Point is ahead on deployment, production, commercials, progress, technology, positioning, firepower and leverage. Critical Point is based in Shanghai, China, Proception in United States. Critical Point is named in 30 signals and Proception in 9.
Critical Point develops and sells OmniHand dexterous robotic hands designed for humanoid platforms, including standard, Lite, and Ultra variants for manipulation and embodied-AI training.
Darker bar: ahead of the other company on that measure.
Critical Point (临界点) was established on 2026-01-14 as the spun-out dexterous hand business of Agibot (Zhiyuan Robotics), which holds 80 percent after contributing RMB 4 million at establishment. Within five months it had raised four rounds, crossed a USD 1 billion post-money valuation on 2026-06-24, delivered over 8,000 OmniHand units and over 10,000 grippers, ranked first in the Chinese dexterous hand market by shipments in Q1 2026, and turned operationally net profitable in Q1 2026, its first full quarter. Founder Xiong Kun graduated from the Hong Kong University of Science and Technology Robotics Institute, participated in the founding of Tencent Robotics X, worked at IDEA Research and Inovance, and joined Agibot in 2024 to lead the dexterous hand business. The flagship OmniHand 3 Ultra-M, launched at ICRA 2026 on 2026-06-02 as the fourth product in under five months, fits 20 active degrees of freedom into 189.5 by 88.5 by 40 millimetres at 630 grams using full direct drive, and the sensing is the differentiator: a miniature visuotactile sensor in each fingertip plus over 300 three-dimensional tactile sensing points across the palm, single-sensor force resolution around 0.005 N, spatial resolution around 0.04 millimetres and sensing density of 50,000 per square centimetre. The 8,000-unit installed base is what separates it from Yuansheng, also in this batch, which discloses none. The reservation is that most detail is company-sourced, no end customer is named, and the 80 p
30 signals name Critical Point.
42 facts on file.
Proception develops and sells ProHand, a dexterous tendon-driven robotic hand designed for humanoid and robotics applications. Its product is a manipulation component with integrated tactile sensing.
Darker bar: ahead of the other company on that measure.
Proception is a US humanoid-robotics component maker developing ProHand 1.0, a 22-DoF tendon-driven dexterous hand, and ProGlove, a wearable tactile-data system for robot-learning workflows. It publicly launched and began shipping its first batch to researchers and robotics companies on Jun-29-26, alongside an $11M seed led by First Round Capital with Y Combinator and BoxGroup; subsequent company activity indicates customer use and additional ProGlove sales. Its distinguishing bet is that humanoid builders will buy dexterous hands rather than develop them internally, but deployment scale, independent validation, named customers, and revenue remain unverified.
9 signals name Proception.
26 facts on file.
Critical Point ranks 7 on the Humanoids 100 with a score of 87; Proception ranks 97 with 51. Critical Point is ahead on deployment, production, commercials, progress, technology, positioning, firepower and leverage. Critical Point is based in Shanghai, China, Proception in United States. Critical Point is named in 30 signals and Proception in 9.
Critical Point ranks 7 on the Humanoids 100 with a score of 87; Proception ranks 97 with 51. Critical Point is ahead on deployment, production, commercials, progress, technology, positioning, firepower and leverage. Critical Point is based in Shanghai, China, Proception in United States. Critical Point is named in 30 signals and Proception in 9. Both company files carry the scores on eight measures, the facts with sources and the latest signals.
Members see every signal and fact behind both companies, the live ranking, the questions the signals answer and the week explained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →